Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.
about
Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this TechnologyQuantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoformsMass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality IndicatorsMass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications.Human proteoforms as new targets for clinical mass spectrometry protein tests.Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.Current trends in quantitative proteomics - an update.Clinical translation of MS-based, quantitative plasma proteomics: status, challenges, requirements, and potential.Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes.Development of a mass spectrometry immunoassay for unambiguous detection of egg allergen traces in wines.
P2860
Q28817809-25DFA616-82A9-4735-B368-EA1DAB43A83BQ35166976-7C4B9713-ED84-411D-8F6D-27CDA4D38DD7Q36072219-5FBA2526-0C5D-4B22-8094-D04F4D368F4EQ36072250-A2F4FE39-A292-4794-9EFA-378B05C56A0EQ36361741-94315379-CA9B-44C8-A5A2-7F5180FF5C25Q37566426-5A2716E1-1B0E-43A7-B195-7939641A6276Q38571078-88EB046E-FDDD-42EC-8A6A-8218AFA09F6FQ38649414-DAF48AF7-7EFB-4B7E-8D06-AFFE9A386D75Q38649742-DD9366B0-8346-4D39-983F-0DDB1CD75046Q38816181-0F9534B7-CE31-485D-8A6E-F6BDD48A65B8Q38832695-07F46A35-2D7F-4F5E-AAFE-186126F7AD33Q39657160-371EA72A-8DB0-4F91-BF59-312267D89DA4Q47163663-09CDF799-3592-44DE-8DD2-85449951CC6BQ51280239-96EF30D2-2E7F-4D24-A5E9-514B5C136E00
P2860
Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Parallel workflow for high-thr ...... ass spectrometric immunoassay.
@ast
Parallel workflow for high-thr ...... ass spectrometric immunoassay.
@en
type
label
Parallel workflow for high-thr ...... ass spectrometric immunoassay.
@ast
Parallel workflow for high-thr ...... ass spectrometric immunoassay.
@en
prefLabel
Parallel workflow for high-thr ...... ass spectrometric immunoassay.
@ast
Parallel workflow for high-thr ...... ass spectrometric immunoassay.
@en
P2093
P2860
P1433
P1476
Parallel workflow for high-thr ...... ass spectrometric immunoassay.
@en
P2093
Bryan Krastins
Chad R Borges
Dawn C Schwenke
Dobrin Nedelkov
Douglas S Rehder
Jason W Jarvis
Luhui Shen
Matthew R Schaab
Olgica Trenchevska
Paul E Oran
P2860
P304
P356
10.1371/JOURNAL.PONE.0092801
P407
P577
2014-03-24T00:00:00Z